O'Day Steven J
Known title: Chief Medical OfficerCIK: 0001845281
Associated companies
Transaction History
| AGEN | ▲ Buy | Grant | 43,497 | $194K | 6/18/2025 | View on chart |
| AGEN | ▲ Buy | Grant | 109,381 | $268K | 1/5/2023 | View on chart |
| AGEN | ▲ Buy | Grant | 101,682 | $255K | 2/2/2022 | View on chart |
| AGEN | ▼ Sell | Open Market | 38,679 | $118K | 1/6/2022 | View on chart |
| AGEN | ▲ Buy | Option Exercise | 100,000 | — | 1/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Agenus Fair Value Adjusted Following Trial Updates and Financing
Agenus saw its estimated fair value rise after recent trial updates and new financing activities. These developments provide context for the stock's current position within its 52-week range. The news highlights ongoing corporate actions that may influence how analysts view the company's future prospects.
Agenus Fair Value Adjusted Following Trial Updates and Financing. Agenus saw its estimated fair value rise after recent trial updates and new financing activities. These developments provide context for the stock's current position within its 52-week range. The news highlights ongoing corporate actions that may influence how analysts view the company's future prospects.